Investigating the effect of resveratrol on polycystic ovary syndrome
Phase 3
- Conditions
- Polycystic ovary syndrome.Polycystic ovary syndromeE28.2
- Registration Number
- IRCT20221106056417N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 56
Inclusion Criteria
Diagnosis of Polycystic ovary syndrome (PCOS) based on Rotterdam criteria
Polycystic ovary syndrome (PCOS) patients who are candidates for ART
Exclusion Criteria
Pregnancy
Adrenal hyperplasia
Androgen-secreting tumors
Hyperprolactinemia
Thyroid dysfunction
Diabetes or impaired glucose tolerance
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method